Actinic Cheilosis: Etiology, Epidemiology, Clinical Manifestations, Diagnosis, and Treatment
COURSE NUMBER: 400
Michaell A. Huber, DDS; David Ojeda Diaz, DDS
Credit Hours:
2 Hour(s)
SHARE
This continuing education course presents the etiology, epidemiology, clinical manifestations, diagnosis, and treatment of actinic cheilosis.
Actinic cheilosis is a chronic degenerative disorder primarily of the lower lip caused by long-t...
(Use this feature to create assignments for your students and staff.)
Overview
This continuing education course presents the etiology, epidemiology, clinical manifestations, diagnosis, and treatment of actinic cheilosis.
Actinic cheilosis is a chronic degenerative disorder primarily of the lower lip caused by long-term exposure to sunlight. It is premalignant and usually occurs in fair-skinned men over 40 years of age. Reducing exposure to sunlight is the single most important measure in preventing actinic cheilosis. Diagnosis is predicated on histological examination of biopsy specimens. Topical chemotherapy may be used in early lesions. Prophylactic ablation or vermilionectomy may be performed in cases where malignant transformation has not yet occurred. The treatment of malignancy is primarily surgical.
Intended Audience:
Dentists, Dental Hygienists, Dental Assistants, Dental Students, Dental Hygiene Students, Dental Assisting Students
Date Course Online:
May 11, 2012
Last Revision Date:
Feb 4, 2022
Course Expiration Date:
Feb 3, 2025
Cost:
Free
Method:
Self-instructional
AGD Subject Code(s):
730
Technical Requirements:
Stable internet connection and the latest version of browser and device software are recommended.
Learning Objectives
Upon the completion of this course, the dental professional should be able to:
- Discuss the etiology and epidemiology of actinic cheilosis.
- Recognize the clinical manifestations of actinic cheilosis.
- Diagnose actinic cheilosis.
- Develop preventive and treatment management strategies for patients with actinic cheilosis.
Disclaimers
- P&G is providing these resource materials to dental professionals. We do not own this content nor are we responsible for any material herein.
- Participants must always be aware of the hazards of using limited knowledge in integrating new techniques or procedures into their practice. Only sound evidence-based dentistry should be used in patient therapy.
Note: Registration is required to take test.
Author(s)
Conflict of Interest Disclosure Statement
- Dr. Huber is a member of the dentalcare.com Advisory Board.
- Dr. Ojeda Díaz reports no conflicts of interest associated with this course.
Michaell A. Huber
DDS
David Ojeda Diaz
DDS
Submission Information
Academy of General Dentistry (AGD) Submission For credit transfers to appear in your AGD account in real time, make sure to add your AGD membership number in the field provided on the “Share Your Test Score” page.
CE Broker For all states that use CE Broker for licensure, “proof of completions” are electronically reported the first of every month. If a course was taken in November, the “proof of completion” will be submitted the beginning of December.
Recognition
Approved PACE Program Provider
THE PROCTER & GAMBLE COMPANY
Nationally Approved PACE Program Provider for FAGD/MAGD credit.
Approval does not imply acceptance by any regulatory authority or AGD endorsement.
8/1/2021 to 7/31/2027
Provider ID# 211886
AADH Approved Program Provider
Procter & Gamble is designated as an approved Provider by the American Academy of Dental Hygiene, Inc. #AADHPGC (January 1, 2024-December 31, 2025). Approval does not imply acceptance by a state or provincial Board of Dentistry. Licensee should maintain this document in the event of an audit.
(Use this feature to create assignments for your students and staff.)